Recessive parkinsonism and mitochondrial function
$147,202ZIAFY2015AGNIH
National Institute On Aging
Investigators
Linked publications, trials & patents
Paper 30133157Paper 29891871Paper 26965687Paper 26464968Paper 24792327Paper 24722488Paper 23962723Paper 21568830Paper 21317550Paper 20940149Paper 20187230Paper 20126261Paper 19703660Paper 19492085Paper 19152501Paper 18218782
Abstract
We have been working on how mitochondrial function influences neuronal survival, particularly in the context of inherited forms of parkinsonism. To this end, we have been examining accelerated aging models including one with a mutation in the mitochondrial polymerase gamma that diminishes proofreading activity of the enzyme, leading to accumulation of mitochondrial DNA mutations., Using a combination of RNA-sequencing and proteomics, we found a long-term disruption of mitochondrial complex I components in mice carrying these mutations. To date, these animals have not shown any dopaminergic cell loss, suggesting that the effect on mitochondrial function is not sufficient to trigger neurodegeneration.
View original record on NIH RePORTER →